BioPharmica Ltd manages a strong portfolio of biomedical technologies emerging from research by leading Universities, Medical Institutes and Hospitals across Australia. The company provides product development and commercial direction, whilst the institutional partner provides the majority of the infrastructure and research expertise.

Technologies on the way to commercialization include diagnosis of infectious disease, brain function monitoring, pre-clinical molecules for use in oncology, metabolic, neurodegenerative, infectious disease, and nanoprobe technology.